Sarcoidosis-related Mortality in the United States from 1988 to 2007
Jeffrey J. Swigris(National Jewish Health), Kevin K. Brown(Health Protection Surveillance Centre), Joshua J. Solomon(National Jewish Health), Tristan J. Huie(National Jewish Health), Evans R. Fernández Pérez(National Jewish Health), David Sprunger(National Jewish Health), Amy L. Olson(National Jewish Health)
American Journal of Respiratory and Critical Care Medicine
February 17, 2011
Cited by 400
Related Papers
Nintedanib in Progressive Fibrosing Interstitial Lung Diseases
|New England Journal of Medicine|2019|2.3k
Efficacy and Safety of Sirolimus in Lymphangioleiomyomatosis
|New England Journal of Medicine|2011|1.1k
Changes in Clinical and Physiologic Variables Predict Survival in Idiopathic Pulmonary Fibrosis
|American Journal of Respiratory and Critical Care Medicine|2003|762
A Placebo-Controlled Trial of Interferon Gamma-1b in Patients with Idiopathic Pulmonary Fibrosis
|New England Journal of Medicine|2004|652